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Premature birth occurs at the time of rapid fetal growth and nutrient accumulation and therefore, establishing postnatal nutrition is essential to achieve appropriate growth and 
maintain biochemical normality [1]. There are significant risks 
with parenteral nutrition such as infection, cholestasis, hepatic 
dysfunction, thinning of gut mucosa, and impairment of enzyme 
production [2,3]. A delay in reaching full enteral feeding (FEF) is 
linked to poor outcome in preterm neonates including postnatal 
growth restriction and failure to thrive, especially in extremely 
low birth weight (ELBW) neonates [4,5]. An increased length 
of time to reach also significantly associated with a poor mental 
outcome in preterm neonates at 24 months corrected age [6]. 
Feeding intolerance is a common problem encountered in preterm 
infants. It may be seen as an early sign of necrotizing enterocolitis 
(NEC), sepsis, or other serious conditions, or it may result from 
gut immaturity [7,8]. The late passage of meconium also delays 
the establishment of oral feed and exaggerates the enterohepatic 
circulation of bilirubin [9].
To promote feeding tolerance and to prevent NEC, various 
strategies have been used such as administration of antenatal 
steroids, early initiation of enteral feeds, exclusive use of breast 
milk, mode of administration of feeds (continuous versus bolus 
feeds), and use of prokinetic and probiotic agents [10]. In addition 
to these modalities, glycerin laxatives (enema or suppositories) 
have also been used to encourage the passage of meconium, 
decrease gastrointestinal transit time, and improve feeding 
tolerance in preterm neonates [11]. We hypothesized that glycerin 
suppository by acting as an osmotic laxative will facilitate early 
meconium evacuation and accelerate feed tolerance. Our study 
was an effort to compare the efficacy of glycerin suppository 
versus no intervention in preterm very low birth weight (VLBW) 
neonates in improving feeding tolerance and to provide an 
accurate picture of the outcome.
MATERIALS AND METHODS
This randomized controlled trial (RCT) was conducted in neonatal 
intensive care unit (NICU) of a tertiary care hospital in western 
Uttar Pradesh, India, from October 2014 to November 2015. 
The study was approved by Institutional Ethics Committee. All 
infants admitted to NICU within 36 h of birth, with a birth weight 
between 1000 and 1500 g or gestational ages between 28 and 
32 weeks, were eligible for inclusion in the study. Infants with 
gastrointestinal or other systemic malformations and infants with 
hemodynamic instability were excluded from the study. When 
a patient meeting inclusion criteria was admitted, the doctor on 
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duty obtained the written informed consent from parents or legal 
guardian. Eligible neonates were randomized to either glycerin 
suppository group or control group. Randomization was done 
by lottery method. Chits numbered from 1 to 20 were prepared, 
placed in a box, and a single chit was drawn from the box. It 
was presumed that, if we get even number, the child would be 
placed in study group, and if we get an odd number, child would 
be placed in control group.
The glycerin suppository administration was performed by 
designated study staff nurse or resident doctor on duty. Those 
in the study group received the drug at a dose of one infant 
glycerin suppository (infant glycerin suppository 1 g, Bhartia 
Pharmaceuticals) once a day from day 2 to day 14 of life, 
irrespective of the passage of stools. Those who were assigned to 
control group did not receive any suppository and no intervention 
was done in this group. Feeds were started in both the groups 
when they became clinically stable, usually between 2nd and 
5th day of life. The feeds were given in the form of intermittent 
boluses every 3 h through orogastric or nasogastric infant feeding 
tube. All infants received either expressed breast milk (EBM) 
and/or preterm infant milk formula (Lactodex LBW, Raptakos, 
Brett & Co. Ltd.); EBM was preferred whenever available. The 
initial feeding volume was 10-20 ml/kg/day and the volume was 
increased daily by 10-20 ml/kg/day, if tolerated until complete 
enteral feeding was achieved i.e., 180 ml/kg/day. Feeding was 
withheld as per clinical condition (suggestive of NEC or other 
intra-abdominal pathology) or if gastric residuals exceeded 50% 
of previous feed volume. Standards of care of NICU did not 
change throughout the study period. Grading up of intravenous 
fluids and starting of trophic feeds was done as before as per 
standard protocol of NICU.
The primary outcome was the time required to achieve FEFs, 
i.e., 180 ml/kg/day for at least 24 h in both the groups. The 
secondary outcome was the correlation of glycerin suppository 
with NEC, time to regain birth weight and adverse effects if any 
following the glycerin suppository. Sample size was calculated 
using the formula for the hypothesis of 2-parallel sample means. 
With the existing feeding practices, the average time taken by an 
infant with birth weight of 1000-1500 g to reach full feeds was 
13 days (standard deviation [SD] 3 days). We hypothesized that 
the glycerin suppository group will reach full feeds by day 10 
(SD 2.8 days) of life. For a difference of 3 days, with an error 
of 0.025 and power of 80%, the estimated sample size was 19 in 
each group. To account for lost to follow-up, 25 infants were to 
be enrolled in each group. Data was analyzed by SPSS software 
version 22.0 (SPSS Inc., Chicago, IL, USA). Continuous measures 
between groups were compared using two-sample t-test. Chi-
square (χ2) test was used to compare proportions. p value<0.05 
was considered statistically significant.
RESULTS
A total of 50 neonates were randomized and allocated to 
either glycerin suppository group or control group. The flow 
chart of the study participants is shown in Fig. 1. The baseline 
characteristics of the study participants were similar in both the 
groups as shown in Table 1 and include birth weight, gestational 
age, sex, administration of antenatal steroids, mode of delivery, 
age at the introduction of feeds, type of milk received and 
hyperbilirubinemia. A total of 19 neonates in both the groups 
were analyzed for the outcome of the study. The outcome of the 
two study groups is shown in Table 2.
DISCUSSION
The results of our RCT did not show any statistically significant 
difference in the time to achieve FEF in glycerin suppository 
group as compared to control group and suggest that the use of 
glycerin suppository to evacuate meconium does not reduce the 
time to reach FEF in preterm LBW neonates versus those not 
Table 1: Baseline characteristics of the study participants
Characteristics Glycerin suppository group (n=25) Control group (n=25) t value p value/result
Birth weight, grams (SD) 1344 (208.3) 1362 (190.9) t=0.3185 0.7515*
Gestational age, weeks (SD) 30.5 (2.63) 30.8 (1.3) t=0.5113 0.6115*
Sex n (%)
Male 14 (56) 16 (64) χ²=0.333 0.5638*
Female 11 (44) 9 (36)
Antenatal glucocorticoids 20 (80) 21 (84) χ²=0.175 0.6757*
Mode of delivery n (%)
Vaginal 12 (48) 13 (52) χ²=0.08 0.7772*
LSCS 13 (52) 12 (48)
Age at introduction of feeds in days (SD) 4.0 (0.9) 4.24 (1.3) t=0.7589 0.4516*
Type of milk received n (%)
Breast milk only 16 (64) 17 (68) χ²=0.089 0.7654*
Breast milk+formula milk 9 (36) 8 (32)
Hyperbilirubinemia 11 (44) 12 (48) χ²=0.175 0.6757*
Mortality 1 (4%) 2 (8%) χ²=0.000 1.000*
*p>0.05=Statistically not significant, χ²=Chi‑square, t=test value. SD: Standard deviation, LSCS: Lower segment cesarean section
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receiving it. There was also no significant difference observed in 
the secondary outcome between the two groups. An observational 
cohort study by Shim et al. reported a significant positive effect 
on feeding tolerance and sepsis prevention in VLBW infants. The 
study group achieved FEF significantly faster than the control 
group (16 days vs. 22.9 days) [4]. Haiden et al. in a RCT found 
that repeated daily application of small volume diluted glycerin 
enemas does not accelerate meconium evacuation and FEF in 
VLBW infants [12].
Khadr et al. in a non-blinded RCT showed that the median 
time to full feeds was 1.6 days shorter in the glycerin suppository 
group; however, it was not statistically significant. The study 
concluded that regular glycerin suppositories did not reduce 
the time to FEF in infants born at <32 weeks gestation, and no 
significant differences were observed in secondary outcomes such 
as incidence of sepsis, NEC, duration of oxygen requirement, 
growth or age at discharge [3]. A double-blinded RCT by 
Shinde et al. concluded that once-daily application of glycerin 
suppository does not accelerate the achievement of full feeds in 
preterm VLBW neonates [11]. Meconium retention is believed 
to result in gastric residuals, distention of abdomen and delayed 
passage of food, possibly by enteroenteric reflexes leading to 
Figure 1: Flow chart of the study participants
Table 2: Comparison of outcomes in glycerin suppository group and control group
Outcome Glycerin suppository group (n=19) Control group (n=19) p value Relative risk (95% CI)
Mean time to reach FEF in days (SD) 11.57 (1.21) 11.84 (1.25) 0.4416 0.67 (−0.539‑1.079)
Feeds withheld, n (%) 4 (21) 3 (15.7) 0.6757 1.33 (0.343-5.170)
NEC, n (%) 1 (5.2) 2 (10.5) 0.5637 0.50 (0.049-5.061)
Mean time to regain birth weight in 
days (SD)
14.15 (1.58) 14.21 (1.57) 0.9069 0.11 (−0.976‑1.096)
Adverse effect 0 0
SD: Standard deviation, FEF: Full enteral feeding, NEC: Necrotizing enterocolitis, CI: Confidence interval
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delayed gastric emptying [13,14]. The passage of first meconium 
only reflects the function of terminal bowel and achievement of 
total meconium evacuation which is delayed in preterm infants 
also correlates better with feed tolerance [15].
The findings of our trial are also not unexpected as the normal 
function of the upper as well as lower gastrointestinal tract is 
essential for complete evacuation of meconium, and also feeding 
tolerance and interventions such as a glycerin suppository or 
small volume enemas do not have an effect on the right colon or 
the small bowel [14]. Whether combination of therapies targeting 
both upper and lower gastrointestinal tract would result in benefits 
needs investigation. A more frequent application (e.g., twice daily) 
or higher dose may be more effective in accelerating meconium 
evacuation [16]. Our study has some limitations also. The 
clinicians were not blinded to treatment allocation, introducing 
an element of bias. ELBW neonates were not included in the trial 
because of the perceived risk and difficulty in the administration 
of glycerin suppository in this population.
CONCLUSION
Regular once-daily administration of glycerin suppositories 
to preterm VLBW neonates for 14 days did not significantly 
reduce the time to achieve FEF in our setting. There was also no 
impact observed on secondary outcomes including the incidence 
of NEC, hyperbilirubinemia, time to regain birth weight, feed 
intolerance, and any adverse effect and mortality with the use 
of glycerin suppository. Our findings do not support the routine 
use of prophylactic glycerin laxatives in clinical practice to 
promote feeding tolerance in preterm low birth weight neonates. 
Additional studies are needed to confirm the effectiveness and 
safety of glycerin laxatives for the prevention and treatment of 
feeding intolerance.
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